nimotuzumab
biocon,oncoscience,daiichi sankyo
['pancsm', 'nimotuzumab', 'pancreatic']
nimotuzumab plus gemcitabine improved overall survival in patients with kras wild-type advanced pancreatic cancer, especially in those who did not need surgery for obstruction of a pancreatic bile duct. #pancsm #asco22 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.